FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

AB Kosmachev

Research Profile

Chemicals & Drugs

Living Beings

Rats

Procedures

Preclinical Drug Evaluations

Concepts & Ideas

Disorders

Anatomy

Brain

Physiology

Drug Interactions

Co-author Network

Publications

TOP 3
SG Dagaev; AB Kosmachev; N E Soloveva; O A Filko; VI Sanotskii; VB Dolgo-Saburov
Effects of cholinoblockers on acetylcholine content in rat striatum in neuroleptic-induced parkinsonism.
SG Dagaev; AB Kosmachev; O A Filko; LG Kubarskaya; AV Khrabrova; VA Beliaev; NP Podosinovikova; NM Libman; VI Sanotskii; VB Dolgo-Saburov
Effect of M4-cholinoceptor blockade on haloperidol-produced catatonic syndrome in rats.
NP Podosinovikova; VV Petrov; AB Kosmachev; LG Kubarskaia; SG Dagaev; VB Dolgo-Saburov
[Differences in prooxidant effect of neuroleptics haloperidol and aminazine].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of AB Kosmachev (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2004: SG Dagaev; AB Kosmachev; N E Soloveva; O A Filko; VI Sanotskii; VB Dolgo-Saburov
Effects of cholinoblockers on acetylcholine content in rat striatum in neuroleptic-induced parkinsonism.
Bulletin of experimental biology and medicine 2004;137(2):164-6.
2004: SG Dagaev; AB Kosmachev; O A Filko; LG Kubarskaya; AV Khrabrova; VA Beliaev; NP Podosinovikova; NM Libman; VI Sanotskii; VB Dolgo-Saburov
Effect of M4-cholinoceptor blockade on haloperidol-produced catatonic syndrome in rats.
Bulletin of experimental biology and medicine 2004;137(2):152-4.
2003: NP Podosinovikova; VV Petrov; AB Kosmachev; LG Kubarskaia; SG Dagaev; VB Dolgo-Saburov
[Differences in prooxidant effect of neuroleptics haloperidol and aminazine].
Eksperimental'naia i klinicheskaia farmakologiia 2003;66(5):53-5.
2003: SG Dagaev; AB Kosmachev; NM Libman; LG Kubarskaya; AV Khrabrova; VI Sanotskii; OA Fil'ko; VB Dolgo-Saburov
Qualitative assessment of selective blockade of M(4)-cholinoreceptors in the whole organism.
Bulletin of experimental biology and medicine 2003;135(5):445-6.
2002: AV Lychakov; V A Belyaev; AB Kosmachev; R I Glukhova; SG Dagaev; VB Dolgo-Saburov
Mathematical analysis of subtypes of muscarinic receptors modulating heart and respiratory rhythms in rats.
Bulletin of experimental biology and medicine 2002;133(5):515-7.
2002: NP Podosinovikova; AB Kosmachev; V D Tonkopiĭ; AO Zagrebin; EA Evdokimova; A M Malov; VV Petrov; VB Dolgo-Saburov
[Daphnia magna for studies of cholinergic preparations].
Eksperimental'naia i klinicheskaia farmakologiia 2002;65(1):73-4.
2002: AB Kosmachev; OA Fil'ko; VV Petrov
[The role of M-cholinoreceptor subtypes in heart rhythm disturbances of various etiology].
Eksperimental'naia i klinicheskaia farmakologiia 2002;65(1):34-6.
2001: NP Podosinovikova; AB Kosmachev; V D Tonkopiĭ; AO Zagrebin; EA Evdokimova; A M Maslov; VV Petrov; VB Dolgo-Saburov
[New approaches to analysis of the interrelationship between cholinergic and dopaminergic mediator systems].
Eksperimental'naia i klinicheskaia farmakologiia 2001;64(6):20-2.
2001: AB Kosmachev; VA Beliaev; AV Khrabrova; NM Libman; VB Dolgo-Saburov
[Effect of M3-choline receptor blockade on the ability of muscarinic antagonists to prevent catalepsy induced by haloperidol in rats].
Eksperimental'naia i klinicheskaia farmakologiia 2001;64(4):10-2.
2001: AB Kosmachev; M B Iakhontova; TA Titkova; OA Fil'ko; S M Ramsh
[Effect of pH on muscarinic antagonist selectivity].
Eksperimental'naia i klinicheskaia farmakologiia 2001;64(3):29-32.
2000: AB Kosmachev; V D Tonkopiĭ; NP Podosinovikova; AO Zagrebin; EA Evdokimova; NM Libman; VV Petrov; VB Dolgo-Saburov
[Characteristics of effects of acetylene amino alcohols M-cholinoreceptor blockers on the dopaminergic system in Daphnia magna].
Eksperimental'naia i klinicheskaia farmakologiia 2000;63(6):15-7.
2000: AB Kosmachev; NP Podosinovikova; NE Solov'eva; V V Dolgo-Saburov
[Subtypes and neuronal localization of muscarinic receptors in rat cerebral hemispheres].
Eksperimental'naia i klinicheskaia farmakologiia 2000;63(5):7-9.
2000: AB Kosmachev; TA Titkova; OA Fil'ko; NM Libman
[Effect of biotransformation on the receptor selectivity of muscarinic antagonists in vivo].
Eksperimental'naia i klinicheskaia farmakologiia 2000;63(4):13-6.
2000: AV Khrabrova; AO Zagrebin; AB Kosmachev; LG Kubarskaia; AV Lychakov; NM Libman; TN Savateeva; TA Titkova; V D Tonkopiĭ; OA Fil'ko; ZI Khobotova
[The evaluation of the specific activity and side effects of the m-cholinergic blocker pentifin compared to other antiparkinson agents].
Eksperimental'naia i klinicheskaia farmakologiia 2000;63(2):21-3.
1999: V D Tonkopiĭ; AB Kosmachev; AO Zagrebin; OA Fil'ko
[The possibility of using Daphnia magna as an alternative test object for evaluating the receptor selectivity of cholinotropic substances].
Eksperimental'naia i klinicheskaia farmakologiia 1999;62(6):23-5.
1999: AB Kosmachev; VA Beliaev; OA Fil'ko; NP Podosinovikova; NE Solov'eva; TA Titkova
[The role of the blockade of separate subtypes of muscarinic receptors in realizing the antidotal effect of m-cholinolytics in dimethyl dichlorovinyl phosphate poisoning].
Eksperimental'naia i klinicheskaia farmakologiia 1999;62(4):55-8.
1999: AV Khrabrova; AB Kosmachev; TA Titkova; A G Chigarev
[The effect of selective m-cholinopositive substances on the antiparkinson activity of atropine].
Eksperimental'naia i klinicheskaia farmakologiia 1999;62(4):7-8.
1999: AB Kosmachev; L A Mukovskiĭ; E B Dolgo-Saburov; ZI Khobotova; LG Kubarskaia
[The role of acetylcholine in the pathogenesis of seizure states of different etiologies].
Eksperimental'naia i klinicheskaia farmakologiia 1999;62(2):7-9.
1998: AB Kosmachev; VA Beliaev; AV Khrabrova; OA Fil'ko; NM Libman
[The antiparkinson activity of muscarinic antagonists depending on their selectivity for individual m-cholinoreceptor subtypes].
Eksperimental'naia i klinicheskaia farmakologiia 1998;61(5):3-5.
1997: AB Kosmachev; OA Fil'ko; VB Dolgo-Saburov; V N Filippov; NP Podosinovikova; NE Solov'eva
[The role of adenylate cyclase and phosphoinositide second messenger systems in regulation of acetylcholine secretion in synapses of the cerebral hemispheres and brain stem in rats].
Eksperimental'naia i klinicheskaia farmakologiia 1997;60(6):3-6.
1997: AB Kosmachev; AV Lychakov; Iu A Saunkina; OA Fil'ko; S M Chigareva
[The role of blockage of various M-cholinoreceptor subtypes in induction of tachycardia in rats].
Eksperimental'naia i klinicheskaia farmakologiia 1997;60(5):44-6.
1997: AB Kosmachev; V N Fillipov; NP Podosinovikova; VB Dolgo-Saburov
[The presynaptic mechanism of interaction of cholinesterase reactivator and muscarinic antagonists in the animal's defence in organophosphate intoxication].
Eksperimental'naia i klinicheskaia farmakologiia 1997;60(3):71-4.
1997: ZI Khobotova; L A Mukovskiĭ; AB Kosmachev; OA Fil'ko; V N Filippov; VB Dolgo-Saburov
[The role of the muscarinic receptors in the pathogenesis of the convulsive state induced by korazol in rats].
Eksperimental'naia i klinicheskaia farmakologiia 1997;60(1):16-8.
1996: AB Kosmachev; V N Filippov; NP Podosinovikova; L F Gorobets; VB Dolgo-Saburov; N M Libman; NE Solov'eva
[New approaches to determining the type classification of presynaptic acetylcholine receptors].
Eksperimental'naia i klinicheskaia farmakologiia 1996;59(5):3-5.
1994: V D Tonkopiĭ; AB Kosmachev; A O Zagrebin
[Comparative pharmacological analysis of M-cholinoreceptors in Daphnia and rats].
Biulleten' eksperimental'noĭ biologii i meditsiny 1994;117(5):497-9.
1994: AB Kosmachev; I M Kosmacheva; M V Iankhotova; V I Kuleshov
[The selectivity of the action of muscarinic agonists in vivo].
Eksperimental'naia i klinicheskaia farmakologiia 1994;57(2):6-8.
1993: V N Filipppov; NP Podosinovikova; AB Kosmachev; VB Dolgo-Saburov
[The mechanisms of the antidotal action of bispyridinium oximes when used in combination with M-cholinolytics in dimethyl dichlorovinyl phosphate poisoning].
Eksperimental'naia i klinicheskaia farmakologiia 1993;56(6):57-8.
1992: AB Kosmachev; M B Iankhotova; I M Kosmacheva
[The selectivity and protective properties of m-cholinolytics in dichlorodivinylphosphate poisoning].
Eksperimental'naia i klinicheskaia farmakologiia 1992;55(3):56-8.
1992: AB Kosmachev; I M Kosmacheva; OA Fil'ko; V I Luleshov
[The role of endogenous K+ in realizing the protective action of M-cholinolytics in chlorophos poisoning].
Eksperimental'naia i klinicheskaia farmakologiia 1992;55(2):55-8.
1991: AB Kosmachev; V N Filippov; I M Kosmacheva; Z I Khobotova; V I Kuleshov
[The possible role of presynaptic effects in realizing the protective action of M-cholinolytics in dimethyl dichlorovinyl phosphate poisoning].
Farmakologiia i toksikologiia 1991;54(4):67-9.
1988: AB Kosmachev; I M Kosmacheva; S M Chigareva
[The ambiguous nature of the action of m-cholinolytics in chlorophos poisoning].
Farmakologiia i toksikologiia 1988;51(5):86-9.
1988: AB Kosmachev; V V Petrov; S M Chigareva
[Relationship between the choline-blocking and protective actions of m-cholinolytics in chlorophos poisoning].
Farmakologiia i toksikologiia 1988;51(3):25-7.